JAK2 and myeloproliferative neoplasm: In addition to the expected differences in full blood count, frequency of splenomegaly, JAK2 V617F allele burden, bone marrow cellularity, depending on specific MPN subtype, we found that the PV patients were significantly older than the other patients (P = 0.04), and ET patients were more often females (P = 0.04).